Yesterday (19 Mar), a federal jury in San Francisco found Monsanto’s Roundup weed killer was a substantial factor in causing cancer in a Californian man, Edwin Hardeman. Mr Hardeman was the first person to challenge Monsanto’s Roundup in a federal court.

During the trial, the 70-year-old testified that he had use the weed killer for a long period of time and at one time got it on his skin before he was diagnosed with cancer.

The Hardeman’s case is considered a landmark trial for hundreds of other plaintiffs in the US with similar claims, which means the verdict could affect future litigation and other cancer patients and families. Monsanto, now owned by the German pharmaceutical company Bayer, is facing more than 11,000 similar lawsuits across the US.

Yesterday’s ruling at a federal court followed a historic verdict last August in which a California state court ruled that Roundup caused the terminal cancer of Dewayne Johnson, a former school groundskeeper. In Mr Johnson’s case, the jury found Monsanto had “acted with malice or oppression” and awarded him US$289 million in damages. The verdict was later reduced by to US$78 million.

Monsanto has continued to argue that Roundup is safe to use and does not cause cancer.

In the next phase of the federal trial, Mr Hardeman’s lawyers will present evidence, including internal Monsanto documents, that could show the company knew the dangers of Roundup and glyphosate and attempted to cover them up. The jury will also weigh liability and damages.

Temasek invests 3 billion euros in Bayer to support its acquisition of Monsanto

After yesterday’s trial, the president of the NGO Environmental Working Group, Ken Cook, said, “Today’s verdict reinforces what another jury found last year, and what scientists with the state of California and the World Health Organization have concluded: Glyphosate causes cancer in people.”

“As similar lawsuits mount, the evidence will grow that Roundup is not safe, and that the company has tried to cover it up,” Mr Cook added.

“The decision by Bayer to purchase Monsanto, a company with a long history of environmental malfeasance, could go down as one of the worst business decisions ever made. The day of reckoning for Bayer and its cancer-causing weedkiller is getting closer.”

In fact, it was Singapore’s Temasek Holdings which helped Bayer to acquire Monsanto.

It was reported in Apr last year that Bayer sold 3.6 per cent stake to Temasek for 3 billion euros at 96.77 euros per share. The money is used as part of Bayer’s plan to takeover Monsanto. Together with its existing holding in Bayer, Temasek would then own about 4 percent in Bayer after the transaction. By Jun, with Temasek’s help, Bayer successfully acquired Monsanto to become the biggest seed and agricultural chemical maker in the world.

Since Bayer’s subsidiary, Monsanto, lost in last Aug’s trial, investors have been viewing Bayer shares as high-risk stocks which they don’t want to include in their portfolios. Bayer has shed more than 30 billion euros from its market capitalization since losing its case in the California state court. It has also cut huge numbers of jobs and sold off parts of the company.

As at yesterday’s closing, Bayer’s share price was 69.70 euros. Since Temasek bought 3 billion euros worth of shares at 96.77 euros in Apr last year, that means it has lost 27.07 euros per share or 28% of the 3 billion euros investment. So, in less than a year, Temasek has lost at least 840 million euros or S$1.3 billion.

Meanwhile, Bayer CEO Baumann who came to Singapore in Jan this year to meet up with Temasek has assured that his company would put up a more “rigorous defence” of the chemical glyphosate used in Monsanto’s weed killer in the impending lawsuits. He continued to deny that Monsanto’s weed killer causes cancer in those cancer sufferers, who are suing Monsanto in the more than 11,000 cases.

The next Roundup trial is scheduled to begin in California state court in Oakland on March 28 next week, involving a couple who claim Roundup has caused their non-Hodgkin’s lymphoma. Even as more cases are waiting to be heard in US courts, more cancer sufferers are also queuing to file suits against Monsanto.

 

Subscribe
Notify of
0 Comments
Inline Feedbacks
View all comments
You May Also Like

PAP’s new candidates show flaws in the system

by Ravi Philemon/ The original intention of the Group Representation Constituency (GRC) system was…

What is the matter with Singapore electricity market?

Opinion: The deregulation of Singapore’s electricity market has led to concerns over power price volatility and potential profiteering. The recent dramatic increase in wholesale electricity prices, due to a convergence of factors including fuel costs and gas supply shortages, has raised questions about the market’s sustainability and fairness.

李显龙要人民和他、行动党一起携手共进

昨日(21日)是人民行动党创党65周年纪念日,新加坡总理暨该党秘书长李显龙发表公开信,呼吁人民能“与他及行动党携手共进,让新加坡迈向更美好未来”。 “今日(21日),人民行动党创党,抱着打造公平社会的使命,以及把发展的成果分享给所有人。” 李显龙声称,从首任秘书长已故李光耀和其团队,再到吴作栋团队,来到他和他的团队,甚至传到第四代领导人团队手上,上述使命都不会改变。 他指出,新加坡自行动党1954年创党以来,面对增加的外来挑战,国内政治格局也在演变。他认为要克服这些挑战和让新加坡政治为国民服务,就需要有能力和效率的政府。 “领袖必须敏捷且坚定,以带领新加坡渡过难关。”他也呼吁国人团结一致,向全球展现一个强大有凝聚力的小红点。 他表示将继续维护国人对行动党政府的信任;续改善国人生活、不分族群宗教,建设团结一致社会。 总理弟弟批行动党“迷失方向” 回溯7月26日,新加坡前进党创党人暨总秘书长陈清木医生,公开抨击今日之良好施政精神已渐乖离,对良好施政之根本,即透明、独立和问责逐渐被侵蚀,感到忧心且痛心,因为这三大根本,乃是建立政府与人民之间信任的基础。 “新加坡需要好的政治体制,即稳健的制衡(checks and balances)机制,这是新加坡人要看到的,希望我们依然能为我们的政府体制引以为傲。” 至于总理弟弟李显扬,在脸书发文,批评“今时今日的行人民行动党,已不再是我父亲领导时期的行动党。它已经迷失了方向。”(Today’s…

乐怡度假村成隔离设施 安置适合出院病患

卫生部也宣布,即日起职总白沙乐怡度假村,将作为社区隔离设施,容纳那些已康复、惟对武汉冠状病毒(COVID-19)测试呈阳性反应的病患。 该部指出,尽管当局已采取措施以减低病毒传播,不过仍作应对病例激增的准备,包括确保当前医疗设施有能力应付大量的病患。 当局指出,乐怡度假村可容纳500人,一些已康复且无需进一步治疗的病患,不过病毒测试仍呈阳性反应,就可安置在这里隔离。 有鉴于一些康复病患已不需医疗护理,让他们在医院隔离就未能有效率地善用医疗资源。 该部指出,社区隔离设施以现有政府隔离设施为蓝本,将以更高的传染病管控水准来管理。上述这些病患将在此隔离,直至他们对病毒测试呈阴性为止。 至于隔离设施的开销则由政府承担。